and non-ischaemic central retinal vein occlusion (CRVO) in two patients. Methods Case reports are presented. Results Non-ischaemic CRVO was manifested by dilated, tortuous retinal veins with ...

Participants who had a previous stroke and/or retinal ... CRAO. central retinalarterial occlusion aspirin ischemic stroke prevention riskfactor This is an open access article distributed in accordance ...

Aims: The aim of the study was to evaluate functional and anatomical changes after intravitreal bevacizumab (Avastin®) in eyes with persistent macular oedema secondary to branch retinal vein occlusion ...

Methods Patients diagnosed as having central retinal vein occlusion ... as the sole treatment of retinal vein occlusions presenting with decreased visual acuity due to macular oedema. This is a ...

Objective To indirectly compare aflibercept, bevacizumab, dexamethasone, ranibizumab and triamcinolone for treatment of macular oedema secondary to central retinal vein occlusion using a ... bias for ...

Higher anti-VEGF injection frequency may lead to greater visual acuity gains in patients with retinal vein occlusion.

- No intervention was shown to perform better for the treatment of central serous chorioretinopathy (CSC) than another. - Larger and higher-quality studies are needed to assess the benefits and ...

The State’s mental health watchdog has expressed concern about an increase in the number of non-compliance findings detected during an inspection of the Central Mental Hospital in Portrane ...

A recently published report associated the development of central retinal artery occlusion (CRAO) with the use of paclitaxel ... The CRAO was seen to have resolved in both eyes on imaging, but ...

The ESCAPE trial enrolled 530 patients with acute ischemic stroke due to medium-vessel occlusion who presented within 12 hours of last being known well and had favorable baseline noninvasive brain ...